| Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality JF Carpenter, TW Randolph, WIM Jiskoot, DJA Crommelin, CR Middaugh, ... Journal of pharmaceutical sciences 98 (4), 1201-1205, 2009 | 650 | 2009 |
| Outbreak of adverse reactions associated with contaminated heparin DB Blossom, AJ Kallen, PR Patel, A Elward, L Robinson, G Gao, ... New England Journal of Medicine 359 (25), 2674-2684, 2008 | 323 | 2008 |
| Developing the nation's biosimilars program S Kozlowski, J Woodcock, K Midthun, R Behrman Sherman New England Journal of Medicine 365 (5), 385-388, 2011 | 258 | 2011 |
| Current and future issues in the manufacturing and development of monoclonal antibodies S Kozlowski, P Swann Advanced drug delivery reviews 58 (5-6), 707-722, 2006 | 222 | 2006 |
| The FDA's assessment of follow-on protein products: a historical perspective J Woodcock, J Griffin, R Behrman, B Cherney, T Crescenzi, B Fraser, ... Nature Reviews Drug Discovery 6 (6), 437-442, 2007 | 215 | 2007 |
| Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex. M Corr, LF Boyd, SR Frankel, S Kozlowski, EA Padlan, DH Margulies The Journal of experimental medicine 176 (6), 1681-1692, 1992 | 176 | 1992 |
| Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression. GR Otten, E Bikoff, RK Ribaudo, S Kozlowski, DH Margulies, RN Germain Journal of immunology (Baltimore, Md.: 1950) 148 (12), 3723-3732, 1992 | 169 | 1992 |
| Excess β2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules S Kozlowski, T Takeshita, WH Boehncke, H Takahashi, LF Boyd, ... Nature 349 (6304), 74-77, 1991 | 163 | 1991 |
| Anti-PEG IgE in anaphylaxis associated with polyethylene glycol ZH Zhou, CA Stone, B Jakubovic, EJ Phillips, G Sussman, JM Park, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (4), 1731-1733. e3, 2021 | 154 | 2021 |
| Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. S Kozlowski, M Corr, T Takeshita, LF Boyd, CD Pendleton, RN Germain, ... The Journal of experimental medicine 175 (6), 1417-1422, 1992 | 120 | 1992 |
| Minimal requirements for peptide mediated activation of CD8+ CTL RC Brower, R England, T Takeshita, S Kozlowski, DH Margulies, ... Molecular immunology 31 (16), 1285-1293, 1994 | 94 | 1994 |
| Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. T Takeshita, H Takahashi, S Kozlowski, JD Ahlers, CD Pendleton, ... Journal of immunology (Baltimore, Md.: 1950) 154 (4), 1973-1986, 1995 | 93 | 1995 |
| Advancing pharmaceutical quality: An overview of science and research in the US FDA’s Office of Pharmaceutical Quality AC Fisher, SL Lee, DP Harris, L Buhse, S Kozlowski, L Yu, M Kopcha, ... International journal of pharmaceutics 515 (1-2), 390-402, 2016 | 90 | 2016 |
| Scientific considerations in the review and approval of generic enoxaparin in the United States S Lee, A Raw, L Yu, R Lionberger, N Ya, D Verthelyi, A Rosenberg, ... Nature Biotechnology 31 (3), 220-226, 2013 | 82 | 2013 |
| Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin. LF Boyd, S Kozlowski, DH Margulies Proceedings of the National Academy of Sciences 89 (6), 2242-2246, 1992 | 79 | 1992 |
| A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity. MG Mage, L Lee, RK Ribaudo, M Corr, S Kozlowski, L McHugh, ... Proceedings of the National Academy of Sciences 89 (22), 10658-10662, 1992 | 70 | 1992 |
| Precision and robustness of 2D-NMR for structure assessment of filgrastim biosimilars H Ghasriani, DJ Hodgson, RG Brinson, I McEwen, LF Buhse, S Kozlowski, ... Nature biotechnology 34 (2), 139-141, 2016 | 69 | 2016 |
| Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008 AW McMahon, RG Pratt, TA Hammad, S Kozlowski, E Zhou, S Lu, ... Pharmacoepidemiology and drug safety 19 (9), 921-933, 2010 | 64 | 2010 |
| Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions JS Goldstein, T Chen, M Brunswick, H Mostowsky, S Kozlowski The Journal of Immunology 160 (7), 3180-3187, 1998 | 63 | 1998 |
| Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides. S Kozlowski, M Corr, M Shirai, LF Boyd, CD Pendleton, JA Berzofsky, ... Journal of immunology (Baltimore, Md.: 1950) 151 (8), 4033-4044, 1993 | 58 | 1993 |
